Defining invasive aspergillosis: What the revised EORTC/MSG definitions have in store

Aspergillosis: From Diagnosis to Prevention

Volumn , Issue , 2010, Pages 423-435

  Donnelly, J Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillosis; Beta D glucan; Consensus; Diagnosis; EORTC; Galactomannan; MSG

Indexed keywords

EID: 84902121372     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2408-4_25     Document Type: Chapter

References (36)

1. Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., Aoun, M., Horst, H. A., Thiebaut, A., Ruhnke, M., Reichert, D., Vianelli, N., Krause, S. W., Olavarria, E. & Herbrecht, R. (2007) Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis, 44, 1289-97.
2. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R. H., Wingard, J. R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P. H., Hodges, M. R., Schlamm, H. T., Troke, P. F. & De Pauw, B. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med, 347, 408-15.
3. Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y. T., Petrini, M., Hardalo, C., Suresh, R. & Angulo-Gonzalez, D. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med, 356, 348-59.
4. Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais De Azevedo, W., Reddy, V., Boparai, N., Pedicone, L., Patino, H. & Durrant, S. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med, 356, 335-47.
5. Maertens, J., Glasmacher, A., Selleslag, D., Ngai, A., Ryan, D., Layton, M., Taylor, A., Sable, C. & Kartsonis, N. (2005) Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. Clin Infect Dis, 41, e9-14.
6. Marr, K. A., Balajee, S. A., Mclaughlin, L., Tabouret, M., Bentsen, C. & Walsh, T. J. (2004) Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis, 190, 641-9.
7. Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H. & Ostrosky-Zeichner, L. (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis, 39, 199-205.
8. Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A. & Rex, J. H. (2005) Multicenter clinical evaluation of the (1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis, 41, 654-9.
9. Upton, A., Leisenring, W. & Marr, K. A. (2006) (1-3) beta-D-glucan assay in the diagnosis of invasive fungal infections. Clin Infect Dis, 42, 1054-6; author reply 6.
10. Cornillet, A., Camus, C., Nimubona, S., Gandemer, V., Tattevin, P., Belleguic, C., Chevrier, S., Meunier, C., Lebert, C., Aupee, M., Caulet-Maugendre, S., Faucheux, M., Lelong, B., Leray, E., Guiguen, C. & Gangneux, J. P. (2006) Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis, 43, 577-84.
11. Garcia-Vidal, C., Upton, A., Kirby, K. A. & Marr, K. A. (2008) Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis, 47, 1041-50.
12. Crassard, N., Hadden, H., Piens, M. A., Pondarre, C., Hadden, R., Galambrun, C., Pracros, J. P., Souillet, G., Basset, T., Berthier, J. C., Philippe, N. & Bertrand, Y. (2008) Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses, 51, 109-16.
13. Pagano, L., Caira, M., Candoni, A., Offidani, M., Fianchi, L., Martino, B., Pastore, D., Picardi, M., Bonini, A., Chierichini, A., Fanci, R., Caramatti, C., Invernizzi, R., Mattei, D., Mitra, M. E., Melillo, L., Aversa, F., Van Lint, M. T., Falcucci, P., Valentini, C. G., Girmenia, C. & Nosari, A. (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica, 91, 1068-75.
14. Subira, M., Martino, R., Rovira, M., Vazquez, L., Serrano, D. & De La Camara, R. (2003) Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol, 82, 80-2.
15. Chamilos, G., Luna, M., Lewis, R. E., Bodey, G. P., Chemaly, R., Tarrand, J. J., Safdar, A., Raad, Ii & Kontoyiannis, D. P. (2006) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica, 91, 986-9.
16. Boudewijns, M., Verweij, P. E. & Melchers, W. J. (2006) Molecular diagnosis of invasive aspergillosis: the long and winding road. Future Microbiol, 1, 283-93.
17. Donnelly, J. P. (2006) Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis, 42, 487-9.
18. Hope, W. W., Walsh, T. J. & Denning, D. W. (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis, 5, 609-22.
19. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., Denning, D. W., Patterson, T. F., Maschmeyer, G., Bille, J., Dismukes, W. E., Herbrecht, R., Hope, W. W., Kibbler, C. C., Kullberg, B. J., Marr, K. A., Munoz, P., Odds, F. C., Perfect, J. R., Restrepo, A., Ruhnke, M., Segal, B. H., Sobel, J. D., Sorrell, T. C., Viscoli, C., Wingard, J. R., Zaoutis, T. & Bennett, J. E. (2008) Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 46, 1813-21.
20. Greene, R. E., Schlamm, H. T., Oestmann, J. W., Stark, P., Durand, C., Lortholary, O., Wingard, J. R., Herbrecht, R., Ribaud, P., Patterson, T. F., Troke, P. F., Denning, D. W., Bennett, J. E., De Pauw, B. E. & Rubin, R. H. (2007) Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis, 44, 373-9.
21. Birsan, T., Taghavi, S. & Klepetko, W. (1998) Treatment of Aspergillus-related ulcerative tracheobronchitis in lung transplant recipients. J Heart Lung Transplant, 17, 437-8.
22. Tasci, S., Schafer, H., Ewig, S., Luderitz, B. & Zhou, H. (2000) Pseudomembraneous Aspergillus fumigatus tracheobronchitis causing life-threatening tracheobronchial obstruction in a mechanically ventilated patient. Intensive Care Med, 26, 143-4.
23. Van Assen, S., Bootsma, G. P., Verweij, P. E., Donnelly, J. P. & Raemakers, J. M. (2000) Aspergillus tracheobronchitis after allogeneic Bone Marrow Transplantation. Bone Marrow Transplant, 26, 1131-2.
24. Hope, W. W., Walsh, T. J. & Denning, D. W. (2005) The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol, 43(Suppl 1), S207-38.
25. Meersseman, W., Lagrou, K., Maertens, J. & Van Wijngaerden, E. (2007) Invasive aspergillosis in the intensive care unit. Clin Infect Dis, 45, 205-16.
26. Maertens, J., Van Eldere, J., Verhaegen, J., Verbeken, E., Verschakelen, J. & Boogaerts, M. (2002) Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis, 186, 1297-306.
27. Sinko, J., Csomor, J., Nikolova, R., Lueff, S., Krivan, G., Remenyi, P., Batai, A. & Masszi, T. (2008) Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey. Transpl Infect Dis, 10, 106-9.
28. Pfeiffer, C. D., Fine, J. P. & Safdar, N. (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis, 42, 1417-27.
29. Maertens, J. A., Klont, R., Masson, C., Theunissen, K., Meersseman, W., Lagrou, K., Heinen, C., Crepin, B., Van Eldere, J., Tabouret, M., Donnelly, J. P. & Verweij, P. E. (2007) Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis, 44, 1329-36.
30. Maertens, J., Theunissen, K., Verbeken, E., Lagrou, K., Verhaegen, J., Boogaerts, M. & Eldere, J. V. (2004) Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol, 126, 852-60.
31. Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T. & Marchetti, O. (2008) 1, 3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis, 46, 878-85.
32. Ellis, M., Al-Ramadi, B., Finkelman, M., Hedstrom, U., Kristensen, J., Ali-Zadeh, H. & Klingspor, L. (2008) Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol, 57, 287-95.
33. Denning, D. W., Kibbler, C. C. & Barnes, R. A. (2003) British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis, 3, 230-40.
34. Go, K. G., Pruim, J., Que, T. H., Vaalburg, W. & Haaxma-Reiche, H. (2000) Evaluation of dissemination studies with FDG whole-body positron emission tomography in patients with suspected metastatic tumours of brain and spine. Acta Neurochir (Wien), 142, 627-31.
35. Fothergill, A. (2008) Proteomics as a potential tool for diagnosis of aspergillosis. In 3rd Advances Against Aspergillosis, Miami, Florida.
36. Kniemeyer, O., Lessing, F. & Brakhage, A. A. (2008) Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus. Med Mycol, 47(1), S248-254.